Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06104904 · ClinicalTrials.gov registry record · NA

Managing Anxiety in Pediatric Primary Care (MAPP)

A NA study of Anxiety and Anxiety Disorders, sponsored by UConn Health.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06104904 is a NA study of Anxiety and Anxiety Disorders that is actively recruiting participants, run by UConn Health. The registered enrollment target is 60 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06104904, a NA study of Anxiety and Anxiety Disorders, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety. The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers (PCPs) in community pediatric primary care clinics. The goal of the AxAP is to enhance the capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general and especially in locations with few mental health specialists. PCPs participating in this study will attend a training, administer the intervention to enrolled youth assigned to the MAPP condition, participate in coaching sessions, and fill out study questionnaires. Families participating in this study will complete evaluations with the study team, receive the intervention from their PCP (if assigned to the MAPP condition), and fill out study questionnaires. Researchers will compare the MAPP intervention to Enhanced Usual Care (EUC; consisting of videos, handouts, and other resources for anxiety reduction) to see the differences, if any, in child outcomes.

Interventions

  • BEHAVIORAL MAPP

Study Locations (1)

Connecticut

  • UConn Health - West Hartford

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-11-20
Est. Completion 2026-01-31
Phase NA

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT06104904

The ClinicalTrials.gov registry entry for NCT06104904 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (86% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which MAPP is the first listed.

NCT06104904 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06104904 about?

NCT06104904 is a clinical study titled "Managing Anxiety in Pediatric Primary Care (MAPP)". The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety. The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to ...

What is the current status of trial NCT06104904?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-11-20. Estimated completion is 2026-01-31.

What conditions does trial NCT06104904 study?

This clinical trial studies the following conditions: Anxiety, Anxiety Disorders.

What interventions are being tested in trial NCT06104904?

The interventions under investigation include: MAPP (BEHAVIORAL).

Who is sponsoring clinical trial NCT06104904?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06104904 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.